TVARDI THERAPEUTICS, INC. Restricted Cash and Investments, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Restricted Cash and Investments, Current of $700.00 thousand as of 2017-09-30, per its 10-Q filed 2017-11-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2018-03-15
- 2017-09-30: Restricted Cash and Investments, Current $700.00K.
- 2017-06-30: Restricted Cash and Investments, Current $700.00K.
- 2017-03-31: Restricted Cash and Investments, Current $700.00K.
- 2016-12-31: Restricted Cash and Investments, Current $700.00K.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2017-09-30 | $700.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $700.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $700.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $700.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |